Previous Close | 50.20 |
Open | 49.46 |
Bid | 46.47 x 1100 |
Ask | 46.94 x 900 |
Day's Range | 46.14 - 50.51 |
52 Week Range | 43.25 - 79.60 |
Volume | 224,680 |
Avg. Volume | 368,788 |
Market Cap | 1.217B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Mar 30, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 67.50 |
Company adds two directors with financial, pharmaceutical, and consumable business expertise.
908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the fourth quarter and full year of 2020 before market open on Tuesday, March 30, 2021. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences.